In the last 12 months, insiders at Adaptive Biotechnologies Corp ($ADPT) filed 381 transactions with the SEC: 0 open-market purchases totaling $0 and 138 sales totaling $76,220,577. Net insider sentiment: net selling.
Adaptive Biotechnologies Corp operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- ROBINS CHAD M (CEO and Chairman) — 39 transactions totaling $36,091,306
- BENZENO SHARON (Chief Commercial Ofc Imm Med) — 38 transactions totaling $16,269,339
- RUBINSTEIN JULIE (President and COO) — 91 transactions totaling $12,180,910
- ROBINS HARLAN S (Chief Scientific Officer) — 23 transactions totaling $10,006,377
- LO FRANCIS (Chief People Officer) — 47 transactions totaling $5,950,849
View all SEC Filings for Adaptive Biotechnologies Corp (ADPT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 470,600.0000 | 163,162,107 | 3.23% | 0.01% |
| April 1, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $14.45 | 451,540.0000 | 163,162,107 | 4.05% | 0.01% |
| April 2, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 466,262.0000 | 163,162,107 | 3.26% | 0.01% |
| April 2, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $14.60 | 447,202.0000 | 163,162,107 | 4.09% | 0.01% |
| April 1, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 96,441.0000 | 163,162,107 | 13.24% | 0.01% |
| April 2, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 81,719.0000 | 163,162,107 | 15.27% | 0.01% |
| March 30, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $12.63 | 460,216.0000 | 163,162,107 | 3.98% | 0.01% |
| March 31, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 474,938.0000 | 163,162,107 | 3.20% | 0.01% |
| March 31, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.45 | 455,878.0000 | 163,162,107 | 4.01% | 0.01% |
| March 27, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 140,607.0000 | 163,162,107 | 9.48% | 0.01% |
| March 30, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 125,885.0000 | 163,162,107 | 10.47% | 0.01% |
| March 27, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 483,614.0000 | 163,162,107 | 3.14% | 0.01% |
| March 27, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 16322 | $13.48 | 464,554.0000 | 163,162,107 | 3.39% | 0.01% |
| March 30, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 479,276.0000 | 163,162,107 | 3.17% | 0.01% |
| March 27, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 2738 | $12.49 | 480,876.0000 | 163,162,107 | 0.57% | 0.00% |
| March 31, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 111,163.0000 | 163,162,107 | 11.69% | 0.01% |
| March 25, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $14.27 | 473,230.0000 | 163,162,107 | 3.87% | 0.01% |
| March 26, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 487,952.0000 | 163,162,107 | 3.11% | 0.01% |
| March 26, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 155,329.0000 | 163,162,107 | 8.66% | 0.01% |
| March 25, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 170,051.0000 | 163,162,107 | 7.97% | 0.01% |
| March 24, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 184,773.0000 | 163,162,107 | 7.38% | 0.01% |
| March 26, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $14.12 | 468,892.0000 | 163,162,107 | 3.91% | 0.01% |
| March 24, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 496,628.0000 | 163,162,107 | 3.05% | 0.01% |
| March 24, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.70 | 477,568.0000 | 163,162,107 | 3.84% | 0.01% |
| March 25, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 492,290.0000 | 163,162,107 | 3.08% | 0.01% |
| March 20, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 10783 | $0.00 | 214,217.0000 | 163,162,107 | 4.79% | 0.01% |
| March 23, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 199,495.0000 | 163,162,107 | 6.87% | 0.01% |
| March 20, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 3939 | $6.55 | 494,521.0000 | 163,162,107 | 0.80% | 0.00% |
| March 19, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.18 | 490,582.0000 | 163,162,107 | 3.74% | 0.01% |
| March 19, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 509,642.0000 | 163,162,107 | 2.97% | 0.01% |
| March 20, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 10783 | $7.27 | 505,304.0000 | 163,162,107 | 2.18% | 0.01% |
| March 20, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.37 | 486,244.0000 | 163,162,107 | 3.77% | 0.01% |
| March 23, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 500,966.0000 | 163,162,107 | 3.03% | 0.01% |
| March 20, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 3939 | $0.00 | 0.0000 | 163,162,107 | 100.00% | 0.00% |
| March 19, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 3,939.0000 | 163,162,107 | 78.89% | 0.01% |
| March 23, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.83 | 481,906.0000 | 163,162,107 | 3.80% | 0.01% |
| March 18, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.18 | 494,920.0000 | 163,162,107 | 3.71% | 0.01% |
| March 18, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 513,980.0000 | 163,162,107 | 2.95% | 0.01% |
| March 16, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 522,656.0000 | 163,162,107 | 2.90% | 0.01% |
| March 18, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 18,661.0000 | 163,162,107 | 44.10% | 0.01% |
| March 16, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.41 | 503,596.0000 | 163,162,107 | 3.65% | 0.01% |
| March 17, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 518,318.0000 | 163,162,107 | 2.92% | 0.01% |
| March 17, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.40 | 499,258.0000 | 163,162,107 | 3.68% | 0.01% |
| March 17, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 33,383.0000 | 163,162,107 | 30.60% | 0.01% |
| March 16, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 48,105.0000 | 163,162,107 | 23.43% | 0.01% |
| March 12, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 77,549.0000 | 163,162,107 | 15.96% | 0.01% |
| March 11, 2026 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 329600 | $13.17 | 2,301,113.0000 | 163,162,107 | 12.53% | 0.20% |
| March 11, 2026 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 140567 | $13.17 | 2,630,713.0000 | 163,162,107 | 5.07% | 0.09% |
| March 11, 2026 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 329600 | $13.17 | 1,522,058.0000 | 163,162,107 | 17.80% | 0.20% |
| March 11, 2026 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 140666 | $13.17 | 1,851,658.0000 | 163,162,107 | 7.06% | 0.09% |
| March 11, 2026 | PISKEL KYLE | Chief Financial Officer | S | Common Stock | 18672 | $13.17 | 259,840.0000 | 163,162,107 | 6.70% | 0.01% |
| March 11, 2026 | BENZENO SHARON | Chief Commercial Ofc Imm Med | S | Common Stock | 63103 | $13.17 | 272,751.0000 | 163,162,107 | 18.79% | 0.04% |
| March 11, 2026 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S | Common Stock | 41338 | $13.17 | 427,775.0000 | 163,162,107 | 8.81% | 0.03% |
| March 11, 2026 | LO FRANCIS | Chief People Officer | S | Common Stock | 30593 | $14.08 | 293,874.0000 | 163,162,107 | 9.43% | 0.02% |
| March 11, 2026 | GRIFFIN MICHELLE RENEE | Director | S | Common Stock | 15394 | $13.91 | 15,625.0000 | 163,162,107 | 49.63% | 0.01% |
| March 13, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 62,827.0000 | 163,162,107 | 18.98% | 0.01% |
| March 11, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 92,271.0000 | 163,162,107 | 13.76% | 0.01% |
| March 13, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $12.96 | 507,934.0000 | 163,162,107 | 3.62% | 0.01% |
| March 13, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 526,994.0000 | 163,162,107 | 2.87% | 0.01% |
| March 12, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 5400 | $13.43 | 512,272.0000 | 163,162,107 | 1.04% | 0.00% |
| March 12, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 13660 | $12.63 | 517,672.0000 | 163,162,107 | 2.57% | 0.01% |
| March 12, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 531,332.0000 | 163,162,107 | 2.85% | 0.01% |
| March 11, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $14.08 | 516,610.0000 | 163,162,107 | 3.56% | 0.01% |
| March 11, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 535,670.0000 | 163,162,107 | 2.83% | 0.01% |
| March 11, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 122523 | $13.17 | 520,948.0000 | 163,162,107 | 19.04% | 0.08% |
| March 6, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 671,207.0000 | 163,162,107 | 2.24% | 0.01% |
| March 6, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 11881 | $12.14 | 683,088.0000 | 163,162,107 | 1.77% | 0.01% |
| March 6, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 30941 | $15.14 | 652,147.0000 | 163,162,107 | 4.53% | 0.02% |
| March 9, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 666,869.0000 | 163,162,107 | 2.26% | 0.01% |
| March 9, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 11881 | $12.14 | 678,750.0000 | 163,162,107 | 1.78% | 0.01% |
| March 9, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 30941 | $14.79 | 647,809.0000 | 163,162,107 | 4.56% | 0.02% |
| March 10, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 662,531.0000 | 163,162,107 | 2.27% | 0.01% |
| March 10, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 400 | $12.14 | 662,931.0000 | 163,162,107 | 0.06% | 0.00% |
| March 10, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19460 | $14.68 | 643,471.0000 | 163,162,107 | 2.94% | 0.01% |
| March 6, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 136,437.0000 | 163,162,107 | 9.74% | 0.01% |
| March 6, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 11881 | $0.00 | 415,820.0000 | 163,162,107 | 2.78% | 0.01% |
| March 9, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 121,715.0000 | 163,162,107 | 10.79% | 0.01% |
| March 9, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 11881 | $0.00 | 403,939.0000 | 163,162,107 | 2.86% | 0.01% |
| March 10, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 106,993.0000 | 163,162,107 | 12.10% | 0.01% |
| March 10, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 400 | $0.00 | 403,539.0000 | 163,162,107 | 0.10% | 0.00% |
| March 5, 2026 | LO FRANCIS | Chief People Officer | S | Common Stock | 38074 | $15.09 | 324,467.0000 | 163,162,107 | 10.50% | 0.02% |
| March 4, 2026 | NEUPERT PETER M | Director | A | Common Stock | 15625 | $0.00 | 240,315.0000 | 163,162,107 | 6.95% | 0.01% |
| March 6, 2026 | ROBINS CHAD M | CEO and Chairman | A | Common Stock | 709220 | $0.00 | 2,771,280.0000 | 163,162,107 | 34.39% | 0.43% |
| March 4, 2026 | ROBINS CHAD M | CEO and Chairman | A | Common Stock | 127813 | $0.00 | 2,062,060.0000 | 163,162,107 | 6.61% | 0.08% |
| March 4, 2026 | GRIFFIN MICHELLE RENEE | Director | A | Common Stock | 15625 | $0.00 | 31,019.0000 | 163,162,107 | 101.50% | 0.01% |
| March 4, 2026 | HERSHBERG ROBERT | Director | A | Common Stock | 15625 | $0.00 | 62,347.0000 | 163,162,107 | 33.44% | 0.01% |
| March 4, 2026 | OWEN KATEY EINTERZ | Director | A | Common Stock | 15625 | $0.00 | 88,254.0000 | 163,162,107 | 21.51% | 0.01% |
| March 4, 2026 | PISKEL KYLE | Chief Financial Officer | A | Common Stock | 61875 | $0.00 | 278,512.0000 | 163,162,107 | 28.56% | 0.04% |
| March 6, 2026 | ROBINS HARLAN S | Chief Scientific Officer | A | Common Stock | 709220 | $0.00 | 1,992,324.0000 | 163,162,107 | 55.27% | 0.43% |
| March 4, 2026 | ROBINS HARLAN S | Chief Scientific Officer | A | Common Stock | 127813 | $0.00 | 1,283,104.0000 | 163,162,107 | 11.06% | 0.08% |
| March 4, 2026 | RUBINSTEIN JULIE | President and COO | A | Common Stock | 81250 | $0.00 | 656,485.0000 | 163,162,107 | 14.12% | 0.05% |
| March 4, 2026 | BENZENO SHARON | Chief Commercial Ofc Imm Med | A | Common Stock | 39063 | $0.00 | 335,854.0000 | 163,162,107 | 13.16% | 0.02% |
| March 4, 2026 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | A | Common Stock | 62500 | $0.00 | 469,113.0000 | 163,162,107 | 15.37% | 0.04% |
| March 4, 2026 | LO FRANCIS | Chief People Officer | A | Common Stock | 44063 | $0.00 | 362,541.0000 | 163,162,107 | 13.84% | 0.03% |
| March 4, 2026 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | A | Common Stock | 59375 | $0.00 | 406,613.0000 | 163,162,107 | 17.10% | 0.04% |
| March 4, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 598,633.0000 | 163,162,107 | 2.52% | 0.01% |
| March 3, 2026 | GRIFFIN MICHELLE RENEE | Director | M | Stock Option (right to buy) | 48044 | $0.00 | 0.0000 | 163,162,107 | 100.00% | 0.03% |
| March 3, 2026 | GRIFFIN MICHELLE RENEE | Director | S | Common Stock | 48044 | $15.30 | 15,394.0000 | 163,162,107 | 75.73% | 0.03% |
| March 3, 2026 | GRIFFIN MICHELLE RENEE | Director | M | Common Stock | 48044 | $3.99 | 63,438.0000 | 163,162,107 | 312.10% | 0.03% |
| March 5, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 11881 | $0.00 | 427,701.0000 | 163,162,107 | 2.70% | 0.01% |
| March 5, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 151,159.0000 | 163,162,107 | 8.88% | 0.01% |
| March 4, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 11881 | $0.00 | 439,582.0000 | 163,162,107 | 2.63% | 0.01% |
| March 4, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 165,881.0000 | 163,162,107 | 8.15% | 0.01% |
| March 3, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 11881 | $0.00 | 451,463.0000 | 163,162,107 | 2.56% | 0.01% |
| March 3, 2026 | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 180,603.0000 | 163,162,107 | 7.54% | 0.01% |
| March 5, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 30941 | $16.00 | 575,235.0000 | 163,162,107 | 5.10% | 0.02% |
| March 5, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 11881 | $12.14 | 606,176.0000 | 163,162,107 | 2.00% | 0.01% |
| March 5, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 594,295.0000 | 163,162,107 | 2.54% | 0.01% |
| March 4, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 30941 | $16.60 | 579,573.0000 | 163,162,107 | 5.07% | 0.02% |
| March 4, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 11881 | $12.14 | 610,514.0000 | 163,162,107 | 1.98% | 0.01% |
| March 3, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 6518 | $16.33 | 583,911.0000 | 163,162,107 | 1.10% | 0.00% |
| March 3, 2026 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 24423 | $15.49 | 590,429.0000 | 163,162,107 | 3.97% | 0.01% |
| March 3, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 11881 | $12.14 | 614,852.0000 | 163,162,107 | 1.97% | 0.01% |
| March 3, 2026 | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 602,971.0000 | 163,162,107 | 2.50% | 0.01% |
| March 2, 2026 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 10000 | $15.72 | 1,169,524.0000 | 163,162,107 | 0.85% | 0.01% |
| March 3, 2026 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 14233 | $16.52 | 1,155,291.0000 | 163,162,107 | 1.22% | 0.01% |
| March 2, 2026 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 289024 | $15.82 | 1,987,330.0000 | 163,162,107 | 12.70% | 0.18% |
| Feb. 27, 2026 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 182891 | $15.99 | 2,276,354.0000 | 163,162,107 | 7.44% | 0.11% |
| March 3, 2026 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 50703 | $15.49 | 1,936,627.0000 | 163,162,107 | 2.55% | 0.03% |
| March 3, 2026 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 2380 | $16.15 | 1,934,247.0000 | 163,162,107 | 0.12% | 0.00% |
| Feb. 4, 2026 | PISKEL KYLE | Chief Financial Officer | S | Common Stock | 2145 | $18.46 | 216,637.0000 | 163,162,107 | 0.98% | 0.00% |
| Feb. 4, 2026 | PISKEL KYLE | Chief Financial Officer | M | Common Stock | 2145 | $12.14 | 218,782.0000 | 163,162,107 | 0.99% | 0.00% |
| Feb. 4, 2026 | PISKEL KYLE | Chief Financial Officer | M | Stock Option (right to buy) | 2145 | $0.00 | 2,146.0000 | 163,162,107 | 49.99% | 0.00% |
| Feb. 2, 2026 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 34668 | $18.60 | 1,187,644.0000 | 163,162,107 | 2.84% | 0.02% |
| Feb. 2, 2026 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 124998 | $18.44 | 2,459,245.0000 | 163,162,107 | 4.84% | 0.08% |
| Feb. 3, 2026 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 8120 | $19.00 | 1,179,524.0000 | 163,162,107 | 0.68% | 0.00% |
| Jan. 12, 2026 | LO FRANCIS | Chief People Officer | M | Common Stock | 7723 | $12.14 | 362,851.0000 | 163,162,107 | 2.17% | 0.00% |
| Jan. 12, 2026 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 14215 | $0.00 | 90,641.0000 | 163,162,107 | 13.56% | 0.01% |
| Jan. 12, 2026 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 21002 | $0.00 | 87,074.0000 | 163,162,107 | 19.43% | 0.01% |
| Jan. 12, 2026 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 7723 | $0.00 | 177,615.0000 | 163,162,107 | 4.17% | 0.00% |
| Jan. 12, 2026 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 36650 | $0.00 | 75,500.0000 | 163,162,107 | 32.68% | 0.02% |
| Jan. 12, 2026 | LO FRANCIS | Chief People Officer | S | Common Stock | 79590 | $17.73 | 318,478.0000 | 163,162,107 | 19.99% | 0.05% |
| Jan. 12, 2026 | LO FRANCIS | Chief People Officer | M | Common Stock | 14215 | $3.99 | 398,068.0000 | 163,162,107 | 3.70% | 0.01% |
| Jan. 12, 2026 | LO FRANCIS | Chief People Officer | M | Common Stock | 21002 | $8.46 | 383,853.0000 | 163,162,107 | 5.79% | 0.01% |
| Jan. 12, 2026 | LO FRANCIS | Chief People Officer | M | Common Stock | 36650 | $7.80 | 355,128.0000 | 163,162,107 | 11.51% | 0.02% |
| Jan. 12, 2026 | PISKEL KYLE | Chief Financial Officer | M | Stock Option (right to buy) | 4290 | $0.00 | 4,291.0000 | 163,162,107 | 49.99% | 0.00% |
| Jan. 12, 2026 | PISKEL KYLE | Chief Financial Officer | S | Common Stock | 4290 | $18.00 | 216,637.0000 | 163,162,107 | 1.94% | 0.00% |
| Jan. 12, 2026 | PISKEL KYLE | Chief Financial Officer | M | Common Stock | 4290 | $12.14 | 220,927.0000 | 163,162,107 | 1.98% | 0.00% |
| Jan. 6, 2026 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 10000 | $16.44 | 1,222,312.0000 | 163,162,107 | 0.81% | 0.01% |
| Jan. 5, 2026 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 124998 | $15.59 | 2,584,243.0000 | 163,162,107 | 4.61% | 0.08% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | S | Common Stock | 4394 | $17.50 | 318,478.0000 | 163,162,107 | 1.36% | 0.00% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 1100 | $0.00 | 112,150.0000 | 163,162,107 | 0.97% | 0.00% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 1100 | $0.00 | 108,076.0000 | 163,162,107 | 1.01% | 0.00% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 2194 | $0.00 | 107,981.0000 | 163,162,107 | 1.99% | 0.00% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | M | Common Stock | 1100 | $7.80 | 319,578.0000 | 163,162,107 | 0.35% | 0.00% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | M | Common Stock | 1100 | $8.46 | 320,678.0000 | 163,162,107 | 0.34% | 0.00% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | M | Common Stock | 2194 | $3.99 | 322,872.0000 | 163,162,107 | 0.68% | 0.00% |
| Jan. 2, 2026 | LO FRANCIS | Chief People Officer | M | Common Stock | 3125 | $3.99 | 321,603.0000 | 163,162,107 | 0.98% | 0.00% |
| Jan. 2, 2026 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 3125 | $0.00 | 104,856.0000 | 163,162,107 | 2.89% | 0.00% |
| Jan. 2, 2026 | LO FRANCIS | Chief People Officer | S | Common Stock | 3125 | $16.08 | 318,478.0000 | 163,162,107 | 0.97% | 0.00% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | M | Common Stock | 1100 | $3.99 | 322,872.0000 | 163,162,107 | 0.34% | 0.00% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | S | Common Stock | 4394 | $17.50 | 318,478.0000 | 163,162,107 | 1.36% | 0.00% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 1100 | $0.00 | 112,150.0000 | 163,162,107 | 0.97% | 0.00% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 1100 | $0.00 | 109,075.0000 | 163,162,107 | 1.00% | 0.00% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 2194 | $0.00 | 106,982.0000 | 163,162,107 | 2.01% | 0.00% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | M | Common Stock | 1100 | $7.80 | 319,578.0000 | 163,162,107 | 0.35% | 0.00% |
| Dec. 22, 2025 | LO FRANCIS | Chief People Officer | M | Common Stock | 2194 | $8.46 | 321,772.0000 | 163,162,107 | 0.69% | 0.00% |
| Dec. 15, 2025 | LO FRANCIS | Chief People Officer | M | Common Stock | 39849 | $3.99 | 432,368.0000 | 163,162,107 | 10.15% | 0.02% |
| Dec. 15, 2025 | LO FRANCIS | Chief People Officer | M | Common Stock | 37750 | $7.80 | 373,096.0000 | 163,162,107 | 11.26% | 0.02% |
| Dec. 15, 2025 | LO FRANCIS | Chief People Officer | M | Common Stock | 19423 | $8.46 | 392,519.0000 | 163,162,107 | 5.21% | 0.01% |
| Dec. 15, 2025 | LO FRANCIS | Chief People Officer | S | Common Stock | 113890 | $15.57 | 318,478.0000 | 163,162,107 | 26.34% | 0.07% |
| Dec. 15, 2025 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 37750 | $0.00 | 113,250.0000 | 163,162,107 | 25.00% | 0.02% |
| Dec. 15, 2025 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 19423 | $0.00 | 109,176.0000 | 163,162,107 | 15.10% | 0.01% |
| Dec. 15, 2025 | LO FRANCIS | Chief People Officer | M | Stock Option (right to buy) | 39849 | $0.00 | 110,175.0000 | 163,162,107 | 26.56% | 0.02% |
| Dec. 10, 2025 | HERSHBERG ROBERT | Director | S | Common Stock | 22968 | $16.00 | 46,722.0000 | 163,162,107 | 32.96% | 0.01% |
| Dec. 4, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Stock Option (right to buy) | 4157 | $0.00 | 112,247.0000 | 163,162,107 | 3.57% | 0.00% |
| Dec. 4, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Stock Option (right to buy) | 4157 | $0.00 | 62,360.0000 | 163,162,107 | 6.25% | 0.00% |
| Dec. 4, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Stock Option (right to buy) | 4290 | $0.00 | 12,871.0000 | 163,162,107 | 25.00% | 0.00% |
| Dec. 4, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | S | Common Stock | 12604 | $16.85 | 296,791.0000 | 163,162,107 | 4.07% | 0.01% |
| Dec. 4, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Common Stock | 4157 | $8.46 | 305,238.0000 | 163,162,107 | 1.38% | 0.00% |
| Dec. 4, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Common Stock | 4157 | $3.99 | 309,395.0000 | 163,162,107 | 1.36% | 0.00% |
| Dec. 4, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Common Stock | 4290 | $12.14 | 301,081.0000 | 163,162,107 | 1.45% | 0.00% |
| Dec. 3, 2025 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 27212 | $18.61 | 1,242,312.0000 | 163,162,107 | 2.14% | 0.02% |
| Dec. 4, 2025 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 10000 | $16.61 | 1,232,312.0000 | 163,162,107 | 0.80% | 0.01% |
| Nov. 28, 2025 | PISKEL KYLE | Chief Financial Officer | M | Common Stock | 94384 | $12.14 | 379,457.0000 | 163,162,107 | 33.11% | 0.06% |
| Nov. 28, 2025 | PISKEL KYLE | Chief Financial Officer | M | Stock Option (right to buy) | 11980 | $0.00 | 0.0000 | 163,162,107 | 100.00% | 0.01% |
| Nov. 28, 2025 | PISKEL KYLE | Chief Financial Officer | M | Stock Option (right to buy) | 3750 | $0.00 | 0.0000 | 163,162,107 | 100.00% | 0.00% |
| Nov. 28, 2025 | PISKEL KYLE | Chief Financial Officer | M | Common Stock | 11980 | $6.55 | 281,323.0000 | 163,162,107 | 4.45% | 0.01% |
| Nov. 28, 2025 | PISKEL KYLE | Chief Financial Officer | M | Common Stock | 3750 | $7.80 | 285,073.0000 | 163,162,107 | 1.33% | 0.00% |
| Nov. 28, 2025 | PISKEL KYLE | Chief Financial Officer | M | Stock Option (right to buy) | 94384 | $0.00 | 8,581.0000 | 163,162,107 | 91.67% | 0.06% |
| Nov. 28, 2025 | PISKEL KYLE | Chief Financial Officer | S | Common Stock | 162820 | $19.50 | 216,637.0000 | 163,162,107 | 42.91% | 0.10% |
| Dec. 1, 2025 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 124998 | $18.94 | 2,709,241.0000 | 163,162,107 | 4.41% | 0.08% |
| Nov. 26, 2025 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 35736 | $19.68 | 2,834,239.0000 | 163,162,107 | 1.25% | 0.02% |
| Nov. 21, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Stock Option (right to buy) | 119809 | $0.00 | 17,161.0000 | 163,162,107 | 87.47% | 0.07% |
| Nov. 20, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Common Stock | 133032 | $8.46 | 525,755.0000 | 163,162,107 | 33.87% | 0.08% |
| Nov. 20, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Common Stock | 68961 | $12.14 | 594,716.0000 | 163,162,107 | 13.12% | 0.04% |
| Nov. 20, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | S | Common Stock | 297925 | $16.54 | 296,791.0000 | 163,162,107 | 50.10% | 0.18% |
| Nov. 21, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Common Stock | 834 | $6.27 | 297,625.0000 | 163,162,107 | 0.28% | 0.00% |
| Nov. 21, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Common Stock | 20834 | $6.55 | 318,459.0000 | 163,162,107 | 7.00% | 0.01% |
| Nov. 21, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Common Stock | 49480 | $6.55 | 367,939.0000 | 163,162,107 | 15.54% | 0.03% |
| Nov. 21, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Common Stock | 34375 | $7.27 | 402,314.0000 | 163,162,107 | 9.34% | 0.02% |
| Nov. 21, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Common Stock | 119809 | $12.14 | 522,123.0000 | 163,162,107 | 29.78% | 0.07% |
| Nov. 21, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Common Stock | 83145 | $3.99 | 605,268.0000 | 163,162,107 | 15.92% | 0.05% |
| Nov. 21, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | S | Common Stock | 308477 | $16.91 | 296,791.0000 | 163,162,107 | 50.97% | 0.19% |
| Nov. 20, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Stock Option (right to buy) | 133032 | $0.00 | 66,517.0000 | 163,162,107 | 66.67% | 0.08% |
| Nov. 20, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Stock Option (right to buy) | 68961 | $0.00 | 136,970.0000 | 163,162,107 | 33.49% | 0.04% |
| Nov. 21, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Stock Option (right to buy) | 834 | $0.00 | 0.0000 | 163,162,107 | 100.00% | 0.00% |
| Nov. 21, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Stock Option (right to buy) | 20834 | $0.00 | 0.0000 | 163,162,107 | 100.00% | 0.01% |
| Nov. 21, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Stock Option (right to buy) | 49480 | $0.00 | 0.0000 | 163,162,107 | 100.00% | 0.03% |
| Nov. 21, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Stock Option (right to buy) | 34375 | $0.00 | 0.0000 | 163,162,107 | 100.00% | 0.02% |
| Nov. 21, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M | Stock Option (right to buy) | 83145 | $0.00 | 116,404.0000 | 163,162,107 | 41.67% | 0.05% |
| Nov. 17, 2025 | PISKEL KYLE | Chief Financial Officer | S | Common Stock | 238 | $14.05 | 269,343.0000 | 163,162,107 | 0.09% | 0.00% |
| Nov. 12, 2025 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 1867 | $15.00 | 2,869,975.0000 | 163,162,107 | 0.07% | 0.00% |
| Nov. 10, 2025 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 86161 | $14.73 | 2,873,088.0000 | 163,162,107 | 2.91% | 0.05% |
| Nov. 10, 2025 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 10000 | $14.82 | 1,269,524.0000 | 163,162,107 | 0.78% | 0.01% |
| Nov. 11, 2025 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 1237 | $14.57 | 2,871,851.0000 | 163,162,107 | 0.04% | 0.00% |
| May 16, 2025 | PISKEL KYLE | Chief Financial Officer | S | Common Stock | 1929 | $8.89 | 269,581.0000 | 147,101,648 | 0.71% | 0.00% |
| May 16, 2025 | PISKEL KYLE | Chief Financial Officer | S | Common Stock | 1929 | $8.89 | 277,396.0000 | 147,101,648 | 0.69% | 0.00% |
| May 15, 2025 | PISKEL KYLE | Chief Financial Officer | A | Common Stock | 7815 | $0.00 | 279,325.0000 | 147,101,648 | 2.88% | 0.01% |
| May 1, 2025 | ROBINS HARLAN S | Chief Scientific Officer | M | Common Stock | 68412 | $6.32 | 1,347,936.0000 | 147,101,648 | 5.35% | 0.05% |
| May 1, 2025 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 68412 | $7.35 | 1,279,524.0000 | 147,101,648 | 5.08% | 0.05% |
| May 1, 2025 | ROBINS HARLAN S | Chief Scientific Officer | M | Stock Option (Right to Buy) | 68412 | $0.00 | 0.0000 | 147,101,648 | 100.00% | 0.05% |
| March 24, 2025 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 1698 | $9.00 | 1,279,524.0000 | 147,101,648 | 0.13% | 0.00% |
| March 24, 2025 | ROBINS HARLAN S | Chief Scientific Officer | M | Stock Option (Right to Buy) | 1698 | $0.00 | 68,412.0000 | 147,101,648 | 2.42% | 0.00% |
| March 24, 2025 | ROBINS HARLAN S | Chief Scientific Officer | M | Common Stock | 1698 | $6.32 | 1,281,222.0000 | 147,101,648 | 0.13% | 0.00% |
| March 13, 2025 | GRIFFIN MICHELLE RENEE | Director | S | Common Stock | 36291 | $7.19 | 15,394.0000 | 147,101,648 | 70.22% | 0.02% |
| March 14, 2025 | PISKEL KYLE | Chief Financial Officer | M | Stock Option (Right to Buy) | 2500 | $0.00 | 0.0000 | 147,101,648 | 100.00% | 0.00% |
| March 14, 2025 | PISKEL KYLE | Chief Financial Officer | M | Common Stock | 2500 | $6.32 | 271,510.0000 | 147,101,648 | 0.93% | 0.00% |
| March 10, 2025 | NEUPERT PETER M | Director | M | Stock Option (right to buy) | 50000 | $0.00 | 0.0000 | 147,101,648 | 100.00% | 0.03% |
| March 12, 2025 | HERSHBERG ROBERT | Director | S | Common Stock | 53000 | $7.59 | 69,690.0000 | 147,101,648 | 43.20% | 0.04% |
| March 10, 2025 | NEUPERT PETER M | Director | S | Common Stock | 10000 | $7.05 | 224,690.0000 | 147,101,648 | 4.26% | 0.01% |
| March 10, 2025 | NEUPERT PETER M | Director | M | Common Stock | 50000 | $4.07 | 234,690.0000 | 147,101,648 | 27.07% | 0.03% |
| March 4, 2025 | NEUPERT PETER M | Director | A | Common Stock | 15394 | $0.00 | 184,690.0000 | 147,101,648 | 9.09% | 0.01% |
| March 4, 2025 | OWEN KATEY EINTERZ | Director | A | Stock Option (right to buy) | 23726 | $0.00 | 23,726.0000 | 147,101,648 | 9999.99% | 0.02% |
| March 4, 2025 | OWEN KATEY EINTERZ | Director | A | Common Stock | 15394 | $0.00 | 72,629.0000 | 147,101,648 | 26.90% | 0.01% |
| March 4, 2025 | Pellini Michael J | Director | A | Stock Option (right to buy) | 23726 | $0.00 | 23,726.0000 | 147,101,648 | 9999.99% | 0.02% |
| March 4, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | A | Stock Option (right to buy) | 165027 | $0.00 | 165,027.0000 | 147,101,648 | 9999.99% | 0.11% |
| March 4, 2025 | GRIFFIN MICHELLE RENEE | Director | A | Stock Option (right to buy) | 23726 | $0.00 | 23,726.0000 | 147,101,648 | 9999.99% | 0.02% |
| March 6, 2025 | GRIFFIN MICHELLE RENEE | Director | S | Common Stock | 15664 | $7.94 | 51,685.0000 | 147,101,648 | 23.26% | 0.01% |
| March 4, 2025 | GRIFFIN MICHELLE RENEE | Director | A | Common Stock | 15394 | $0.00 | 67,349.0000 | 147,101,648 | 29.63% | 0.01% |
| March 4, 2025 | HERSHBERG ROBERT | Director | A | Stock Option (right to buy) | 23726 | $0.00 | 23,726.0000 | 147,101,648 | 9999.99% | 0.02% |
| March 4, 2025 | HERSHBERG ROBERT | Director | A | Common Stock | 15394 | $0.00 | 122,690.0000 | 147,101,648 | 14.35% | 0.01% |
| March 4, 2025 | NEUPERT PETER M | Director | A | Stock Option (right to buy) | 23726 | $0.00 | 23,726.0000 | 147,101,648 | 9999.99% | 0.02% |
| March 6, 2025 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 102218 | $7.64 | 2,959,249.0000 | 147,101,648 | 3.34% | 0.07% |
| March 5, 2025 | ROBINS CHAD M | CEO and Chairman | A | Common Stock | 247117 | $0.00 | 3,061,467.0000 | 147,101,648 | 8.78% | 0.17% |
| March 5, 2025 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 36145 | $6.99 | 2,814,350.0000 | 147,101,648 | 1.27% | 0.02% |
| March 5, 2025 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 81206 | $6.98 | 2,850,495.0000 | 147,101,648 | 2.77% | 0.06% |
| March 4, 2025 | ROBINS CHAD M | CEO and Chairman | A | Common Stock | 355000 | $0.00 | 2,931,701.0000 | 147,101,648 | 13.78% | 0.24% |
| March 5, 2025 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 56053 | $6.99 | 1,279,524.0000 | 147,101,648 | 4.20% | 0.04% |
| March 5, 2025 | ROBINS HARLAN S | Chief Scientific Officer | S | Common Stock | 40603 | $6.98 | 1,335,577.0000 | 147,101,648 | 2.95% | 0.03% |
| March 4, 2025 | ROBINS HARLAN S | Chief Scientific Officer | A | Common Stock | 355000 | $0.00 | 1,376,180.0000 | 147,101,648 | 34.76% | 0.24% |
| March 5, 2025 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19461 | $6.99 | 588,249.0000 | 147,101,648 | 3.20% | 0.01% |
| March 5, 2025 | RUBINSTEIN JULIE | President and COO | S | Common Stock | 40044 | $6.98 | 607,710.0000 | 147,101,648 | 6.18% | 0.03% |
| March 4, 2025 | RUBINSTEIN JULIE | President and COO | A | Common Stock | 175000 | $0.00 | 647,754.0000 | 147,101,648 | 37.02% | 0.12% |
| March 5, 2025 | PISKEL KYLE | Chief Financial Officer | S | Common Stock | 6964 | $6.99 | 269,010.0000 | 147,101,648 | 2.52% | 0.00% |
| March 5, 2025 | PISKEL KYLE | Chief Financial Officer | S | Common Stock | 253 | $6.98 | 275,974.0000 | 147,101,648 | 0.09% | 0.00% |
| March 5, 2025 | PISKEL KYLE | Chief Financial Officer | S | Common Stock | 3103 | $6.97 | 276,227.0000 | 147,101,648 | 1.11% | 0.00% |
| March 4, 2025 | PISKEL KYLE | Chief Financial Officer | A | Common Stock | 125000 | $0.00 | 279,330.0000 | 147,101,648 | 81.00% | 0.08% |
| March 5, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | S | Common Stock | 3065 | $6.99 | 392,723.0000 | 147,101,648 | 0.77% | 0.00% |
| March 5, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | S | Common Stock | 41600 | $6.98 | 395,788.0000 | 147,101,648 | 9.51% | 0.03% |
| March 4, 2025 | BENZENO SHARON | Chief Commercial Ofc Imm Med | A | Common Stock | 109973 | $0.00 | 437,388.0000 | 147,101,648 | 33.59% | 0.07% |
| March 4, 2025 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | A | Stock Option (right to buy) | 180029 | $0.00 | 180,029.0000 | 147,101,648 | 9999.99% | 0.12% |
| March 5, 2025 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S | Common Stock | 26023 | $6.98 | 347,238.0000 | 147,101,648 | 6.97% | 0.02% |
| March 4, 2025 | LO FRANCIS | Chief People Officer | A | Common Stock | 99976 | $0.00 | 356,221.0000 | 147,101,648 | 39.02% | 0.07% |
| March 5, 2025 | LO FRANCIS | Chief People Officer | S | Common Stock | 7085 | $6.98 | 349,136.0000 | 147,101,648 | 1.99% | 0.00% |
| March 5, 2025 | LO FRANCIS | Chief People Officer | S | Common Stock | 13790 | $6.99 | 335,346.0000 | 147,101,648 | 3.95% | 0.01% |
| March 4, 2025 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | A | Common Stock | 119971 | $0.00 | 373,261.0000 | 147,101,648 | 47.37% | 0.08% |
| March 4, 2025 | LO FRANCIS | Chief People Officer | A | Stock Option (right to buy) | 150024 | $0.00 | 150,024.0000 | 147,101,648 | 9999.99% | 0.10% |
| March 4, 2025 | Pellini Michael J | Director | A | Common Stock | 15394 | $0.00 | 69,690.0000 | 147,101,648 | 28.35% | 0.01% |
| Feb. 20, 2025 | ROBINS CHAD M | CEO and Chairman | M | Common Stock | 99107 | $6.32 | 2,675,808.0000 | 147,101,648 | 3.85% | 0.07% |
| Feb. 20, 2025 | ROBINS CHAD M | CEO and Chairman | M | Stock Option (right to buy) | 99107 | $0.00 | 0.0000 | 147,101,648 | 100.00% | 0.07% |
| Feb. 19, 2025 | ROBINS CHAD M | CEO and Chairman | M | Stock Option (right to buy) | 186080 | $0.00 | 99,107.0000 | 147,101,648 | 65.25% | 0.13% |
| Feb. 19, 2025 | ROBINS CHAD M | CEO and Chairman | M | Common Stock | 186080 | $6.32 | 2,762,781.0000 | 147,101,648 | 7.22% | 0.13% |
| Feb. 20, 2025 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 99107 | $8.44 | 2,576,701.0000 | 147,101,648 | 3.70% | 0.07% |
| Feb. 19, 2025 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 186080 | $8.46 | 2,576,701.0000 | 147,101,648 | 6.74% | 0.13% |
| Feb. 18, 2025 | ROBINS CHAD M | CEO and Chairman | M | Common Stock | 211160 | $6.32 | 2,787,861.0000 | 147,101,648 | 8.19% | 0.14% |
| Feb. 18, 2025 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 211160 | $8.50 | 2,576,701.0000 | 147,101,648 | 7.57% | 0.14% |
| Feb. 13, 2025 | ROBINS CHAD M | CEO and Chairman | M | Common Stock | 100287 | $6.32 | 2,676,988.0000 | 147,101,648 | 3.89% | 0.07% |
| Feb. 13, 2025 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 100287 | $8.44 | 2,576,701.0000 | 147,101,648 | 3.75% | 0.07% |
| Feb. 14, 2025 | ROBINS CHAD M | CEO and Chairman | M | Common Stock | 158921 | $6.32 | 2,735,622.0000 | 147,101,648 | 6.17% | 0.11% |
| Feb. 14, 2025 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 158921 | $8.46 | 2,576,701.0000 | 147,101,648 | 5.81% | 0.11% |
| Feb. 18, 2025 | ROBINS CHAD M | CEO and Chairman | M | Stock Option (right to buy) | 211160 | $0.00 | 285,187.0000 | 147,101,648 | 42.54% | 0.14% |
| Feb. 14, 2025 | ROBINS CHAD M | CEO and Chairman | M | Stock Option (right to buy) | 158921 | $0.00 | 496,347.0000 | 147,101,648 | 24.25% | 0.11% |
| Feb. 13, 2025 | ROBINS CHAD M | CEO and Chairman | M | Stock Option (right to buy) | 100287 | $0.00 | 655,268.0000 | 147,101,648 | 13.27% | 0.07% |
| Nov. 18, 2024 | PISKEL KYLE | Chief Financial Officer | S | Common Stock | 248 | $4.98 | 154,330.0000 | 147,516,398 | 0.16% | 0.00% |
| Oct. 8, 2024 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | M | Common Stock | 5000 | $1.98 | 253,290.0000 | 147,516,398 | 2.01% | 0.00% |
| Oct. 8, 2024 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | M | Stock Option (right to buy) | 5000 | $0.00 | 0.0000 | 147,516,398 | 100.00% | 0.00% |
| Aug. 22, 2024 | Taylor Stacy L | SVP and General Counsel | S | Common Stock | 26922 | $4.50 | 139,365.0000 | 144,383,294 | 16.19% | 0.02% |
| May 15, 2024 | PISKEL KYLE | Chief Financial Officer | A | Common Stock | 31260 | $0.00 | 154,578.0000 | 144,383,294 | 25.35% | 0.02% |
| March 12, 2024 | NEUPERT PETER M | Director | M | Common Stock | 15000 | $0.84 | 169,296.0000 | 144,383,294 | 9.72% | 0.01% |
| March 12, 2024 | NEUPERT PETER M | Director | M | Stock Option (right to buy) | 15000 | $0.00 | 0.0000 | 144,383,294 | 100.00% | 0.01% |
| March 4, 2024 | HERSHBERG ROBERT | Director | A | Stock Option (right to buy) | 48044 | $0.00 | 48,044.0000 | 144,383,294 | 9999.99% | 0.03% |
| March 4, 2024 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | A | Stock Option (right to buy) | 199549 | $0.00 | 199,549.0000 | 144,383,294 | 9999.99% | 0.14% |
| March 5, 2024 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S | Common Stock | 6975 | $3.44 | 248,290.0000 | 144,383,294 | 2.73% | 0.00% |
| March 5, 2024 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S | Common Stock | 6016 | $3.43 | 255,265.0000 | 144,383,294 | 2.30% | 0.00% |
| March 4, 2024 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | A | Common Stock | 132979 | $0.00 | 261,281.0000 | 144,383,294 | 103.65% | 0.09% |
| March 5, 2024 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 42794 | $3.43 | 2,576,701.0000 | 144,383,294 | 1.63% | 0.03% |
| March 5, 2024 | ROBINS CHAD M | CEO and Chairman | S | Common Stock | 5879 | $3.44 | 2,619,495.0000 | 144,383,294 | 0.22% | 0.00% |
| March 4, 2024 | ROBINS CHAD M | CEO and Chairman | A | Common Stock | 354610 | $0.00 | 2,625,374.0000 | 144,383,294 | 15.62% | 0.25% |
| March 5, 2024 | PETERSON TYCHO | Chief Financial Officer | S | Common Stock | 15456 | $3.44 | 531,553.0000 | 144,383,294 | 2.83% | 0.01% |
| March 4, 2024 | PETERSON TYCHO | Chief Financial Officer | A | Common Stock | 147790 | $0.00 | 547,009.0000 | 144,383,294 | 37.02% | 0.10% |
| March 4, 2024 | ROBINS HARLAN S | Chief Scientific Officer | A | Common Stock | 354610 | $0.00 | 1,021,180.0000 | 144,383,294 | 53.20% | 0.25% |
| March 5, 2024 | RUBINSTEIN JULIE | President | S | Common Stock | 13490 | $3.56 | 472,754.0000 | 144,383,294 | 2.77% | 0.01% |
| March 5, 2024 | RUBINSTEIN JULIE | President | S | Common Stock | 25580 | $3.43 | 486,244.0000 | 144,383,294 | 5.00% | 0.02% |
| March 4, 2024 | RUBINSTEIN JULIE | President | A | Common Stock | 175000 | $0.00 | 511,824.0000 | 144,383,294 | 51.96% | 0.12% |
| March 4, 2024 | BENZENO SHARON | Chief Commercial Ofc Imm Med | A | Stock Option (right to buy) | 199549 | $0.00 | 199,549.0000 | 144,383,294 | 9999.99% | 0.14% |
| March 5, 2024 | BENZENO SHARON | Chief Commercial Ofc Imm Med | S | Common Stock | 18644 | $3.44 | 327,415.0000 | 144,383,294 | 5.39% | 0.01% |
| March 5, 2024 | BENZENO SHARON | Chief Commercial Ofc Imm Med | S | Common Stock | 10746 | $3.43 | 346,059.0000 | 144,383,294 | 3.01% | 0.01% |
| March 4, 2024 | BENZENO SHARON | Chief Commercial Ofc Imm Med | A | Common Stock | 132979 | $0.00 | 356,805.0000 | 144,383,294 | 59.41% | 0.09% |
| March 4, 2024 | LO FRANCIS | Chief People Officer | A | Stock Option (right to buy) | 150024 | $0.00 | 150,024.0000 | 144,383,294 | 9999.99% | 0.10% |
| March 5, 2024 | LO FRANCIS | Chief People Officer | S | Common Stock | 1813 | $3.44 | 256,245.0000 | 144,383,294 | 0.70% | 0.00% |
| March 5, 2024 | LO FRANCIS | Chief People Officer | S | Common Stock | 12887 | $3.43 | 258,058.0000 | 144,383,294 | 4.76% | 0.01% |
| March 4, 2024 | LO FRANCIS | Chief People Officer | A | Common Stock | 99976 | $0.00 | 270,945.0000 | 144,383,294 | 58.48% | 0.07% |
| March 4, 2024 | Taylor Stacy L | SVP and General Counsel | A | Stock Option (right to buy) | 60010 | $0.00 | 60,010.0000 | 144,383,294 | 9999.99% | 0.04% |
| March 5, 2024 | Taylor Stacy L | SVP and General Counsel | S | Common Stock | 6609 | $3.44 | 166,287.0000 | 144,383,294 | 3.82% | 0.00% |
| March 5, 2024 | Taylor Stacy L | SVP and General Counsel | S | Common Stock | 6772 | $3.43 | 172,896.0000 | 144,383,294 | 3.77% | 0.00% |
| March 4, 2024 | Taylor Stacy L | SVP and General Counsel | A | Common Stock | 39990 | $0.00 | 179,668.0000 | 144,383,294 | 28.63% | 0.03% |
| March 5, 2024 | PISKEL KYLE | Principal Accounting Officer | S | Common Stock | 7727 | $3.43 | 123,318.0000 | 144,383,294 | 5.90% | 0.01% |
| March 4, 2024 | PISKEL KYLE | Principal Accounting Officer | A | Common Stock | 43740 | $0.00 | 131,045.0000 | 144,383,294 | 50.10% | 0.03% |
| March 4, 2024 | GRIFFIN MICHELLE RENEE | Director | A | Stock Option (right to buy) | 48044 | $0.00 | 48,044.0000 | 144,383,294 | 9999.99% | 0.03% |
| March 4, 2024 | GRIFFIN MICHELLE RENEE | Director | A | Common Stock | 31328 | $0.00 | 51,955.0000 | 144,383,294 | 151.88% | 0.02% |
| March 4, 2024 | HERSHBERG ROBERT | Director | A | Common Stock | 31328 | $0.00 | 107,296.0000 | 144,383,294 | 41.24% | 0.02% |
| March 4, 2024 | NEUPERT PETER M | Director | A | Stock Option (right to buy) | 48044 | $0.00 | 48,044.0000 | 144,383,294 | 9999.99% | 0.03% |
| March 4, 2024 | NEUPERT PETER M | Director | A | Common Stock | 31328 | $0.00 | 154,296.0000 | 144,383,294 | 25.48% | 0.02% |
| March 4, 2024 | OWEN KATEY EINTERZ | Director | A | Stock Option (right to buy) | 48044 | $0.00 | 48,044.0000 | 144,383,294 | 9999.99% | 0.03% |
| March 4, 2024 | OWEN KATEY EINTERZ | Director | A | Common Stock | 31328 | $0.00 | 57,235.0000 | 144,383,294 | 120.92% | 0.02% |
| March 4, 2024 | Pellini Michael J | Director | A | Stock Option (right to buy) | 48044 | $0.00 | 48,044.0000 | 144,383,294 | 9999.99% | 0.03% |
| March 4, 2024 | Pellini Michael J | Director | A | Common Stock | 31328 | $0.00 | 54,296.0000 | 144,383,294 | 136.40% | 0.02% |
| Dec. 13, 2023 | NEUPERT PETER M | Director | M | Common Stock | 100000 | $0.84 | 122,968.0000 | 142,515,917 | 435.39% | 0.07% |
| Dec. 13, 2023 | NEUPERT PETER M | Director | M | Stock Option (right to buy) | 100000 | $0.00 | 0.0000 | 142,515,917 | 100.00% | 0.07% |
| Nov. 16, 2023 | PISKEL KYLE | Principal Accounting Officer | S | Common Stock | 259 | $4.13 | 87,305.0000 | 142,515,917 | 0.30% | 0.00% |
| Aug. 8, 2023 | SOOD NITIN | Chief Commercial Officer, MRD | S | Common Stock | 10550 | $6.54 | 214,808.0000 | 142,515,917 | 4.68% | 0.01% |
| Aug. 7, 2023 | SOOD NITIN | Chief Commercial Officer, MRD | S | Common Stock | 5652 | $6.78 | 225,358.0000 | 142,515,917 | 2.45% | 0.00% |
| June 20, 2023 | PETERSON TYCHO | Chief Financial Officer | M | Stock Option (right to buy) | 134961 | $0.00 | 447,868.0000 | 142,515,917 | 23.16% | 0.09% |
| June 20, 2023 | PETERSON TYCHO | Chief Financial Officer | S | Common Stock | 70000 | $8.14 | 464,180.0000 | 142,515,917 | 13.10% | 0.05% |
| June 20, 2023 | PETERSON TYCHO | Chief Financial Officer | M | Common Stock | 134961 | $7.30 | 534,180.0000 | 142,515,917 | 33.81% | 0.09% |
| June 20, 2023 | PETERSON TYCHO | Chief Financial Officer | S | Common Stock | 64961 | $8.14 | 399,219.0000 | 142,515,917 | 13.99% | 0.05% |
| June 15, 2023 | PETERSON TYCHO | Chief Financial Officer | M | Stock Option (right to buy) | 14328 | $0.00 | 582,829.0000 | 142,515,917 | 2.40% | 0.01% |
| June 15, 2023 | PETERSON TYCHO | Chief Financial Officer | S | Common Stock | 14328 | $8.53 | 399,219.0000 | 142,515,917 | 3.46% | 0.01% |
| June 15, 2023 | PETERSON TYCHO | Chief Financial Officer | S | Common Stock | 55672 | $8.53 | 399,219.0000 | 142,515,917 | 12.24% | 0.04% |
| June 15, 2023 | PETERSON TYCHO | Chief Financial Officer | M | Common Stock | 14328 | $7.30 | 413,547.0000 | 142,515,917 | 3.59% | 0.01% |
| June 2, 2023 | PETERSON TYCHO | Chief Financial Officer | S | Common Stock | 38000 | $7.16 | 454,891.0000 | 142,515,917 | 7.71% | 0.03% |
| April 11, 2023 | ADAMS R MARK | Chief Operating Officer | S | Common Stock | 2308 | $8.63 | 175,361.0000 | 142,515,917 | 1.30% | 0.00% |
| April 10, 2023 | ADAMS R MARK | Chief Operating Officer | S | Common Stock | 817 | $8.50 | 177,669.0000 | 142,515,917 | 0.46% | 0.00% |
| March 27, 2023 | GRIFFIN MICHELLE RENEE | Director | S | Common Stock | 2341 | $8.49 | 20,627.0000 | 142,515,917 | 10.19% | 0.00% |
| March 6, 2023 | ADAMS R MARK | Chief Operating Officer | S | Common Stock | 6529 | $8.57 | 195,641.0000 | 142,515,917 | 3.23% | 0.00% |
| March 6, 2023 | ADAMS R MARK | Chief Operating Officer | A | Common Stock | 88652 | $0.00 | 202,170.0000 | 142,515,917 | 78.10% | 0.06% |
| March 6, 2023 | Taylor Stacy L | SVP and General Counsel | A | Stock Option (right to buy) | 128599 | $0.00 | 128,599.0000 | 142,515,917 | 9999.99% | 0.09% |
| March 7, 2023 | Taylor Stacy L | SVP and General Counsel | S | Common Stock | 13387 | $8.60 | 139,678.0000 | 142,515,917 | 8.75% | 0.01% |
| March 6, 2023 | Taylor Stacy L | SVP and General Counsel | S | Common Stock | 5491 | $8.57 | 153,065.0000 | 142,515,917 | 3.46% | 0.00% |
| March 6, 2023 | Taylor Stacy L | SVP and General Counsel | A | Common Stock | 85697 | $0.00 | 158,556.0000 | 142,515,917 | 117.62% | 0.06% |
| March 6, 2023 | LO FRANCIS | Chief People Officer | A | Stock Option (right to buy) | 128599 | $0.00 | 128,599.0000 | 142,515,917 | 9999.99% | 0.09% |
| March 6, 2023 | LO FRANCIS | Chief People Officer | S | Common Stock | 6816 | $8.57 | 170,969.0000 | 142,515,917 | 3.83% | 0.00% |
| March 6, 2023 | LO FRANCIS | Chief People Officer | A | Common Stock | 85697 | $0.00 | 177,785.0000 | 142,515,917 | 93.06% | 0.06% |
| March 6, 2023 | PISKEL KYLE | Principal Accounting Officer | S | Common Stock | 229 | $8.58 | 87,564.0000 | 142,515,917 | 0.26% | 0.00% |
| March 6, 2023 | PISKEL KYLE | Principal Accounting Officer | S | Common Stock | 3300 | $8.57 | 87,793.0000 | 142,515,917 | 3.62% | 0.00% |
| March 6, 2023 | PISKEL KYLE | Principal Accounting Officer | A | Common Stock | 43735 | $0.00 | 91,093.0000 | 142,515,917 | 92.35% | 0.03% |
| March 6, 2023 | Trigg Leslie | Director | A | Common Stock | 14775 | $0.00 | 25,907.0000 | 142,515,917 | 132.73% | 0.01% |
| March 6, 2023 | Conroy Kevin T | Director | A | Stock Option (right to buy) | 23329 | $0.00 | 23,329.0000 | 142,515,917 | 9999.99% | 0.02% |
| March 6, 2023 | Conroy Kevin T | Director | A | Common Stock | 14775 | $0.00 | 22,968.0000 | 142,515,917 | 180.34% | 0.01% |
| March 6, 2023 | GRIFFIN MICHELLE RENEE | Director | A | Stock Option (right to buy) | 23329 | $0.00 | 23,329.0000 | 142,515,917 | 9999.99% | 0.02% |
| March 6, 2023 | GRIFFIN MICHELLE RENEE | Director | A | Common Stock | 14775 | $0.00 | 22,968.0000 | 142,515,917 | 180.34% | 0.01% |
| March 6, 2023 | HERSHBERG ROBERT | Director | A | Stock Option (right to buy) | 23329 | $0.00 | 23,329.0000 | 142,515,917 | 9999.99% | 0.02% |
| March 6, 2023 | HERSHBERG ROBERT | Director | A | Common Stock | 14775 | $0.00 | 75,968.0000 | 142,515,917 | 24.14% | 0.01% |
| March 6, 2023 | NEUPERT PETER M | Director | A | Stock Option (right to buy) | 23329 | $0.00 | 23,329.0000 | 142,515,917 | 9999.99% | 0.02% |
| March 6, 2023 | NEUPERT PETER M | Director | A | Common Stock | 14775 | $0.00 | 22,968.0000 | 142,515,917 | 180.34% | 0.01% |
| March 6, 2023 | OWEN KATEY EINTERZ | Director | A | Stock Option (right to buy) | 23329 | $0.00 | 23,329.0000 | 142,515,917 | 9999.99% | 0.02% |
| March 6, 2023 | OWEN KATEY EINTERZ | Director | A | Common Stock | 14775 | $0.00 | 25,907.0000 | 142,515,917 | 132.73% | 0.01% |
| March 6, 2023 | Pellini Michael J | Director | A | Stock Option (right to buy) | 23329 | $0.00 | 23,329.0000 | 142,515,917 | 9999.99% | 0.02% |
| March 6, 2023 | Pellini Michael J | Director | A | Common Stock | 14775 | $0.00 | 22,968.0000 | 142,515,917 | 180.34% | 0.01% |
| March 6, 2023 | Trigg Leslie | Director | A | Stock Option (right to buy) | 23329 | $0.00 | 23,329.0000 | 142,515,917 | 9999.99% | 0.02% |
| March 6, 2023 | ROBINS CHAD M | CEO and Chairman | A | Common Stock | 354610 | $0.00 | 2,270,764.0000 | 142,515,917 | 18.51% | 0.25% |
| March 6, 2023 | ROBINS HARLAN S | Chief Scientific Officer | A | Common Stock | 354610 | $0.00 | 666,570.0000 | 142,515,917 | 113.67% | 0.25% |
| March 6, 2023 | RUBINSTEIN JULIE | President | A | Stock Option (right to buy) | 199549 | $0.00 | 199,549.0000 | 142,515,917 | 9999.99% | 0.14% |
| March 6, 2023 | RUBINSTEIN JULIE | President | S | Common Stock | 22668 | $8.57 | 336,824.0000 | 142,515,917 | 6.31% | 0.02% |
| March 6, 2023 | RUBINSTEIN JULIE | President | A | Common Stock | 132979 | $0.00 | 359,492.0000 | 142,515,917 | 58.71% | 0.09% |
| March 6, 2023 | SOOD NITIN | Chief Commercial Officer, MRD | A | Stock Option (right to buy) | 199549 | $0.00 | 199,549.0000 | 142,515,917 | 9999.99% | 0.14% |
| March 7, 2023 | SOOD NITIN | Chief Commercial Officer, MRD | S | Common Stock | 9813 | $8.60 | 231,010.0000 | 142,515,917 | 4.07% | 0.01% |
| March 6, 2023 | SOOD NITIN | Chief Commercial Officer, MRD | S | Common Stock | 6661 | $8.57 | 240,823.0000 | 142,515,917 | 2.69% | 0.00% |
| March 6, 2023 | SOOD NITIN | Chief Commercial Officer, MRD | A | Common Stock | 132979 | $0.00 | 247,484.0000 | 142,515,917 | 116.13% | 0.09% |
| March 6, 2023 | BENZENO SHARON | Chief Commercial Ofc Imm Med | A | Stock Option (right to buy) | 199549 | $0.00 | 199,549.0000 | 142,515,917 | 9999.99% | 0.14% |
| March 6, 2023 | BENZENO SHARON | Chief Commercial Ofc Imm Med | S | Common Stock | 11749 | $8.57 | 223,826.0000 | 142,515,917 | 4.99% | 0.01% |
| March 6, 2023 | BENZENO SHARON | Chief Commercial Ofc Imm Med | A | Common Stock | 132979 | $0.00 | 235,575.0000 | 142,515,917 | 129.61% | 0.09% |
| March 6, 2023 | PETERSON TYCHO | Chief Financial Officer | A | Stock Option (right to buy) | 177377 | $0.00 | 177,377.0000 | 142,515,917 | 9999.99% | 0.12% |
| March 6, 2023 | PETERSON TYCHO | Chief Financial Officer | A | Common Stock | 118203 | $0.00 | 492,891.0000 | 142,515,917 | 31.55% | 0.08% |
| March 6, 2023 | ADAMS R MARK | Chief Operating Officer | A | Stock Option (right to buy) | 133033 | $0.00 | 133,033.0000 | 142,515,917 | 9999.99% | 0.09% |
| March 7, 2023 | ADAMS R MARK | Chief Operating Officer | S | Common Stock | 17155 | $8.60 | 178,486.0000 | 142,515,917 | 8.77% | 0.01% |
| Feb. 2, 2023 | HERSHBERG ROBERT | Director | M | Common Stock | 53000 | $0.45 | 61,193.0000 | 142,515,917 | 646.89% | 0.04% |
| Feb. 2, 2023 | HERSHBERG ROBERT | Director | M | Stock Option (Right to Buy) | 53000 | $0.00 | 0.0000 | 142,515,917 | 100.00% | 0.04% |
| Jan. 9, 2023 | ADAMS R MARK | Chief Operating Officer | S | Common Stock | 995 | $8.50 | 115,648.0000 | 142,515,917 | 0.85% | 0.00% |
| Jan. 10, 2023 | ADAMS R MARK | Chief Operating Officer | S | Common Stock | 2130 | $8.58 | 113,518.0000 | 142,515,917 | 1.84% | 0.00% |